ICSH Recommendations for Monocyte Cell Lineage Morphologic Identification, Nomenclature Harmonization, and Utilization as a Biomarker.

Journal: International journal of laboratory hematology
Published Date:

Abstract

Monocytes are key components of the Mononuclear Phagocyte System, crucial in immune defense, inflammation, and tissue repair. Accurate identification and classification of monocyte lineage cells are essential for diagnosing both reactive and clonal hematologic disorders. However, morphological criteria and nomenclature inconsistencies have hindered reproducibility, particularly with the rise of automated and AI-driven diagnostic tools. The International Council for Standardization in Haematology (ICSH) Monocyte Working Group (MWG) was convened to establish standardized morphological definitions, harmonize nomenclature for monocytes and their precursors, and evaluate their clinical utility as biomarkers. Data were collected from global laboratories, combined with an extensive literature review and consensus feedback from the ICSH General Assembly. The MWG proposes a three-category morphological classification: blasts and blast equivalents (monoblasts and promonocytes), immature monocytes, and mature monocytes. The recommendations reaffirm the importance of morphological analysis, cytochemical staining, and flow cytometry for accurate diagnosis. Emerging automated parameters, such as monocyte distribution width (MDW), and ratios like lymphocyte/monocyte (LMR) and neutrophil/monocyte (NMR), are also recognized as valuable adjunctive biomarkers. Cytogenetic and molecular results may also impact the utilization of monocytes as a biomarker. These harmonized recommendations aim to improve diagnostic accuracy, support the development of machine learning tools, and facilitate consistent reporting across laboratories worldwide.

Authors

  • Gina Zini
    Catholic University of Sacred Heart, Hematology Service, Rome, Italy.
  • Yoon Hwan Chang
    Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Giuseppe d'Onofrio
    Catholic University of Sacred Heart, Hematology Service, Rome, Italy.
  • John Frater
    Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
  • Ulrich Germing
    Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
  • Anna Merino
    Biochemistry and Molecular Genetics, Biomedical Diagnostic Center, Hospital Clinic of Barcelona, Barcelona, Catalonia, Spain [email protected].
  • Olga Pozdnyakova
    Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • David Ross
    Biosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, MD 20899.
  • Claudio Romulo Siqueira Filho
    Catholic University São Camilo in São Paulo, São Paulo, Brazil.
  • Akiyoshi Takami
    Division of Hematology, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.
  • Erber Wendy
    PathWest Laboratory Medicine, Perth, Western Australia, Australia.

Keywords

No keywords available for this article.